The Manufacturers Life Insurance Company lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 3.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 332,198 shares of the medical research company’s stock after selling 13,511 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.10% of Agilent Technologies worth $19,703,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BlackRock Inc. increased its position in Agilent Technologies by 1.2% in the 2nd quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock valued at $1,387,400,000 after acquiring an additional 273,119 shares in the last quarter. Vanguard Group Inc. increased its position in Agilent Technologies by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock valued at $1,310,374,000 after acquiring an additional 637,698 shares in the last quarter. State Street Corp increased its position in Agilent Technologies by 1.0% in the 1st quarter. State Street Corp now owns 14,457,425 shares of the medical research company’s stock valued at $764,348,000 after acquiring an additional 147,518 shares in the last quarter. JPMorgan Chase & Co. increased its position in Agilent Technologies by 45.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after acquiring an additional 3,779,099 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in Agilent Technologies by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,721,557 shares of the medical research company’s stock valued at $339,346,000 after acquiring an additional 84,801 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/17/the-manufacturers-life-insurance-company-lowers-holdings-in-agilent-technologies-inc-a.html.

Agilent Technologies, Inc. (NYSE:A) opened at 66.91 on Tuesday. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $67.82. The company has a market cap of $21.53 billion, a price-to-earnings ratio of 47.79 and a beta of 1.30. The company’s 50-day moving average is $65.36 and its 200 day moving average is $60.01.

Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post $2.32 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s dividend payout ratio is presently 27.32%.

In other Agilent Technologies news, insider Mark Doak sold 12,421 shares of the stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $61.57, for a total transaction of $764,760.97. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Didier Hirsch sold 15,555 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the sale, the chief financial officer now directly owns 178,557 shares of the company’s stock, valued at approximately $11,784,762. The disclosure for this sale can be found here. Insiders have sold a total of 165,720 shares of company stock valued at $10,488,739 in the last three months.

Several research analysts have recently issued reports on the stock. Deutsche Bank AG reaffirmed a “buy” rating and issued a $66.00 target price on shares of Agilent Technologies in a research note on Thursday, June 22nd. Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a research note on Monday, July 10th. BidaskClub raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 11th. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and raised their target price for the company from $42.92 to $60.73 in a research note on Wednesday, July 12th. Finally, Barclays PLC reaffirmed a “buy” rating and issued a $67.00 target price on shares of Agilent Technologies in a research note on Wednesday, July 19th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $65.12.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Stock Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related stocks with our FREE daily email newsletter.